DPI’s investment in Biopharm’s pharmaceutical operations in Algeria for USD 25million

Lead party: Development Partners International (DPI) (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Biopharm Group (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Deal amount: US$25m · Fund:…


Lead party: Development Partners International (DPI) (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Biopharm Group (public company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Algeria

Transaction type: Investment · Asset class: Private Equity · Strategy: Growth Equity · Instrument: Equity · Deal amount: US$25m · Fund: African Development Partners I (ADP I)

Lead investor/buyer: Development Partners International (DPI) · Investors/buyers: Development Partners International (DPI)

Legal advisers: not identified in the source record.

Source: announced 1 March 2013. Original announcement: dpi-llp.com.